Literature DB >> 23739767

Integrated platform for genome-wide screening and construction of high-density genetic interaction maps in mammalian cells.

Martin Kampmann1, Michael C Bassik, Jonathan S Weissman.   

Abstract

A major challenge of the postgenomic era is to understand how human genes function together in normal and disease states. In microorganisms, high-density genetic interaction (GI) maps are a powerful tool to elucidate gene functions and pathways. We have developed an integrated methodology based on pooled shRNA screening in mammalian cells for genome-wide identification of genes with relevant phenotypes and systematic mapping of all GIs among them. We recently demonstrated the potential of this approach in an application to pathways controlling the susceptibility of human cells to the toxin ricin. Here we present the complete quantitative framework underlying our strategy, including experimental design, derivation of quantitative phenotypes from pooled screens, robust identification of hit genes using ultra-complex shRNA libraries, parallel measurement of tens of thousands of GIs from a single double-shRNA experiment, and construction of GI maps. We describe the general applicability of our strategy. Our pooled approach enables rapid screening of the same shRNA library in different cell lines and under different conditions to determine a range of different phenotypes. We illustrate this strategy here for single- and double-shRNA libraries. We compare the roles of genes for susceptibility to ricin and Shiga toxin in different human cell lines and reveal both toxin-specific and cell line-specific pathways. We also present GI maps based on growth and ricin-resistance phenotypes, and we demonstrate how such a comparative GI mapping strategy enables functional dissection of physical complexes and context-dependent pathways.

Entities:  

Keywords:  RNA interference; epistasis; functional genomics; human genome; synthetic lethality

Mesh:

Substances:

Year:  2013        PMID: 23739767      PMCID: PMC3690882          DOI: 10.1073/pnas.1307002110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Java Treeview--extensible visualization of microarray data.

Authors:  Alok J Saldanha
Journal:  Bioinformatics       Date:  2004-06-04       Impact factor: 6.937

2.  Systematic genetic analysis with ordered arrays of yeast deletion mutants.

Authors:  A H Tong; M Evangelista; A B Parsons; H Xu; G D Bader; N Pagé; M Robinson; S Raghibizadeh; C W Hogue; H Bussey; B Andrews; M Tyers; C Boone
Journal:  Science       Date:  2001-12-14       Impact factor: 47.728

3.  Beyond secondary structure: primary-sequence determinants license pri-miRNA hairpins for processing.

Authors:  Vincent C Auyeung; Igor Ulitsky; Sean E McGeary; David P Bartel
Journal:  Cell       Date:  2013-02-14       Impact factor: 41.582

4.  A robust toolkit for functional profiling of the yeast genome.

Authors:  Xuewen Pan; Daniel S Yuan; Dong Xiang; Xiaoling Wang; Sharon Sookhai-Mahadeo; Joel S Bader; Philip Hieter; Forrest Spencer; Jef D Boeke
Journal:  Mol Cell       Date:  2004-11-05       Impact factor: 17.970

5.  Optimization of duplex stability and terminal asymmetry for shRNA design.

Authors:  Olga V Matveeva; Yibin Kang; Alexey N Spiridonov; Pål Saetrom; Vladimir A Nemtsov; Aleksey Y Ogurtsov; Yury D Nechipurenko; Svetlana A Shabalina
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

6.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

7.  Quantitative genetic-interaction mapping in mammalian cells.

Authors:  Assen Roguev; Dale Talbot; Gian Luca Negri; Michael Shales; Gerard Cagney; Sourav Bandyopadhyay; Barbara Panning; Nevan J Krogan
Journal:  Nat Methods       Date:  2013-02-13       Impact factor: 28.547

8.  A systematic mammalian genetic interaction map reveals pathways underlying ricin susceptibility.

Authors:  Michael C Bassik; Martin Kampmann; Robert Jan Lebbink; Shuyi Wang; Marco Y Hein; Ina Poser; Jimena Weibezahn; Max A Horlbeck; Siyuan Chen; Matthias Mann; Anthony A Hyman; Emily M Leproust; Michael T McManus; Jonathan S Weissman
Journal:  Cell       Date:  2013-02-08       Impact factor: 41.582

9.  A strategy for extracting and analyzing large-scale quantitative epistatic interaction data.

Authors:  Sean R Collins; Maya Schuldiner; Nevan J Krogan; Jonathan S Weissman
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  69 in total

1.  Massively parallel high-order combinatorial genetics in human cells.

Authors:  Alan S L Wong; Gigi C G Choi; Allen A Cheng; Oliver Purcell; Timothy K Lu
Journal:  Nat Biotechnol       Date:  2015-08-17       Impact factor: 54.908

2.  Mapping a diversity of genetic interactions in yeast.

Authors:  Jolanda van Leeuwen; Charles Boone; Brenda J Andrews
Journal:  Curr Opin Syst Biol       Date:  2017-08-12

3.  Exploration of Benzothiazole Rhodacyanines as Allosteric Inhibitors of Protein-Protein Interactions with Heat Shock Protein 70 (Hsp70).

Authors:  Hao Shao; Xiaokai Li; Michael A Moses; Luke A Gilbert; Chakrapani Kalyanaraman; Zapporah T Young; Margarita Chernova; Sara N Journey; Jonathan S Weissman; Byron Hann; Matthew P Jacobson; Len Neckers; Jason E Gestwicki
Journal:  J Med Chem       Date:  2018-07-13       Impact factor: 7.446

4.  CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons.

Authors:  Ruilin Tian; Mariam A Gachechiladze; Connor H Ludwig; Matthew T Laurie; Jason Y Hong; Diane Nathaniel; Anika V Prabhu; Michael S Fernandopulle; Rajan Patel; Mehrnoosh Abshari; Michael E Ward; Martin Kampmann
Journal:  Neuron       Date:  2019-08-15       Impact factor: 17.173

5.  Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys.

Authors:  Stefan Mockenhaupt; Stefanie Grosse; Daniel Rupp; Ralf Bartenschlager; Dirk Grimm
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

6.  CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells.

Authors:  S John Liu; Max A Horlbeck; Seung Woo Cho; Harjus S Birk; Martina Malatesta; Daniel He; Frank J Attenello; Jacqueline E Villalta; Min Y Cho; Yuwen Chen; Mohammad A Mandegar; Michael P Olvera; Luke A Gilbert; Bruce R Conklin; Howard Y Chang; Jonathan S Weissman; Daniel A Lim
Journal:  Science       Date:  2016-12-15       Impact factor: 47.728

7.  A CRISPR Approach to Neurodegenerative Diseases.

Authors:  Martin Kampmann
Journal:  Trends Mol Med       Date:  2017-05-04       Impact factor: 11.951

8.  Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia.

Authors:  Karina A Kruth; Mimi Fang; Dawne N Shelton; Ossama Abu-Halawa; Ryan Mahling; Hongxing Yang; Jonathan S Weissman; Mignon L Loh; Markus Müschen; Sarah K Tasian; Michael C Bassik; Martin Kampmann; Miles A Pufall
Journal:  Blood       Date:  2017-04-19       Impact factor: 22.113

9.  Defining a Cancer Dependency Map.

Authors:  Aviad Tsherniak; Francisca Vazquez; Phil G Montgomery; Barbara A Weir; Gregory Kryukov; Glenn S Cowley; Stanley Gill; William F Harrington; Sasha Pantel; John M Krill-Burger; Robin M Meyers; Levi Ali; Amy Goodale; Yenarae Lee; Guozhi Jiang; Jessica Hsiao; William F J Gerath; Sara Howell; Erin Merkel; Mahmoud Ghandi; Levi A Garraway; David E Root; Todd R Golub; Jesse S Boehm; William C Hahn
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

10.  CRISPR-based genetic interaction maps inform therapeutic strategies in cancer.

Authors:  Poornima Ramkumar; Martin Kampmann
Journal:  Transl Cancer Res       Date:  2018-02       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.